Benori’s Post

📣 Aiming for a sustainable healthcare system that balances patient impact, financial constraints, and environmental considerations is crucial for our future. Currently, there is a gap in practical knowledge for conducting harmonized impact assessments. To address this, our #Transpharm research group has been dedicated to developing a holistic framework for integrated sustainability assessment of pharmaceuticals. 🌍 Covering all three dimensions of sustainability 👣 Focusing on both burdens (i.e., footprint) and benefits (i.e., handprint) 💊 Applicable to a wide range of pharmaceutical products and treatments 🏥 Pursuing assessments throughout the entire life cycle of Pharmaceuticals, with expansion to the full healthcare pathway Lisa Van Wilder, Lieselot Boone, Ad Ragas, Caroline Moermond, Lowik Pieters, Dr. Aissa Rechlin, Rodrigo Vidaurre, Jo Dewulf

Sustainability is very much a pertinent topic right now, particularly so in pharma, with the industry significantly contributing to greenhouse gas emissions. 🌱 As the demand for sustainable practices and products continues to rise, the need for pharma companies to align with these objectives is becoming imperative. In a two-part blog, Julian Northen, Solid State Manager at Onyx Scientific, and Chris Atherton, Commercial Manager at Onyx Scientific, discuss the challenges the pharma industry faces on the journey to sustainability, whilst highlighting ways in which pharma companies can overcome them. 🌟 Read part one here: https://loom.ly/v9sMzcM #Sustainability #Pharma #CDMO

The substantial carbon footprint of the pharmaceutical industry underscores the pressing need for sustainable initiatives. In this article, Alf Goebel, CEO of advanco, emphasizes the sector's responsibility to address environmental concerns, social impact, and governance practices. He highlights collaboration as crucial for advancing ESG goals and underscores advanco's pivotal role in shaping sustainability efforts within pharmaceutical and life sciences industries. Read more to discover advanco’s contributions to driving sustainability forward.   https://lnkd.in/dhJqKQtX #pharma #lifesciences #serialization #trackandtrace #traceability #ESG #sustainability

NEW ARTICLE! DCAT Sustainability Summit to Drive Greener Solutions for Pharma and Biopharma The global bio/pharmaceutical industry is reaching a developmental junction, with the challenges of sustainable and environmentally friendly business practices playing on the minds of industry leaders. The issue is indeed a high priority for the sector, with companies formalising sustainability goals as well as adding a sustainability role at the corporate and site level, driven in part by legislation that outlines compliance requirements. Only this week, the UK government set out new draft guidelines for businesses, essentially instructing them to make fewer drugs for the sake of the environment and to meet net zero goals. Added to that, 2023’s proposed amendments to EU pharmaceutical legislation by the European Commission, it’s fair to say change is coming to the industry whether it is prepared or not. Continue reading here: https://lnkd.in/d_KS6W76 DCAT (Drug, Chemical & Associated Technologies Association) Carol Lee Donna Gruol Paolo Magri #bio #pharma #biopharma #pharmaceutical #sustainability #networking #event #dcat

𝗜𝘀 𝘁𝗵𝗲 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝘀𝗲𝗰𝘁𝗼𝗿 𝗿𝗲𝗮𝗱𝘆 𝗳𝗼𝗿 𝗴𝗲𝗻𝘂𝗶𝗻𝗲 𝘀𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗹𝗲 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻?🕵️♀️♻🧪 Concluding their presentation “Approaches to enhance sustainability in the pharmaceutical sector”, NIRAS's sustainability experts, Lone Gjørret and Lis Thodberg asked the audience this question at the IDA Life Science Annual Conference. Over the years, the pharmaceutical sector has made significant strides in optimizing and implementing more sustainable initiatives. This progress is largely fuelled by the industry's ambitious targets. The real question is whether there are designs and solutions that can truly propel the industry's green transition - and if so, what's needed to make it happen? 💡 Lis and Lone addressed the pressing need for the pharmaceutical industry to shift from merely undergoing transitions and working with continuous improvements to embracing full-scale transformation. Why this change is necessary and what it entails comes with a lot of questions to which we can’t claim to have all the answers, but approaches like decarbonization, setting fresh water targets, and industrial symbiosis are three initiatives that could potentially support a concrete transformation. You can learn more about NIRAS’s thoughts on e.g. decarbonisation of industrial sites and facilities in our article on the topic: https://lnkd.in/d8qMqpx5  

It was great to deliver this interactive workshop with Maria Diffley. Lots of good questions and comments. While the Corporate Sustainability Reporting Directive (CSRD) introduces mandatory reporting requirements for companies, approaching it as an opportunity rather than a burden can help companies unlock strategic benefits. It encourages businesses to integrate sustainability into their core strategies, leading to enhanced value creation, stakeholder engagement, innovation, and resilience. Embracing CSRD as an integral part of business strategy, rather than just a regulatory requirement, can unlock several advantages: 1) Strategic Alignment and Value Creation Viewing CSRD beyond compliance encourages companies to integrate sustainability into their core business strategies. 2) Operational Efficiency and Innovation The process of collecting and analysing sustainability data for CSRD reporting can uncover opportunities for operational improvements and cost savings. 3) Proactive Risk Management Beyond compliance, the CSRD encourages companies to adopt a more proactive approach to identifying and managing sustainability-related risks. 4) Enhanced Stakeholder Engagement CSRD provides a framework for companies to communicate their sustainability performance and impact in a structured and transparent way. 5) Long-term Resilience and Sustainability CSRD can be a catalyst for companies to transition towards more sustainable business models that are not only better prepared to withstand future challenges but also contribute positively to societal goals. 6) Attracting Talent and Building Corporate Culture A strong commitment to sustainability, demonstrated through comprehensive reporting and strategic actions beyond mere compliance, can make companies more attractive to current and prospective employees. 

Opportunities to leverage sustainable practices across the pharma ecosystem exist today, but implementing them requires a truly integrated approach across the value chain. Discover Ecolab's new E-book "Powering Sustainability in Pharma" to discover insights around: ✅ Best practices in Pharma sustainability 🌍 The pharmaceutical industry’s role in mitigating climate change 💡 How Ecolab's innovation can support customers sustainability goals Download your free copy in the link below: https://lnkd.in/dFz-_PVs

The life sciences and healthcare sector are responsible for 5% of global carbon emissions, with a significant portion stemming from the production of APIs. McKinsey & Company research reveals that decarbonizing API manufacturing can cut emissions by 90% by 2040. But while many API manufacturers have set #decarbonization goals, few have concrete plans in place. Read on to learn why collaboration across the supply chain is key to achieving these targets: https://lnkd.in/gZrRMD3x by Jasmin Jessen for Sustainability Magazine 

Just read an article about the importance of sustainability in the pharmaceutical industry. It's crucial for pharma companies to be more green and careful with nature. Happy to say that at my job, we help make this happen. Proud to be making a difference! Check out this interesting read on why sustainability is crucial for pharma's supply chain future. Link to the article: https://lnkd.in/eiTNtRHy #digital #training #sustainability #pharma #manufacturing

Takeda: sustainability ownership at every level The pharmaceutical company Takeda believes it can only improve the health of its customers, if it is also #sustainable. Speaking at Environment Analyst’s recent #Sustainability Delivery Summit in Boston, Johanna Jobin, the company’s global head of #environment and sustainability, discussed the challenges sustainability leaders are facing and how they are working with consultants to help solve them. https://lnkd.in/ejgFiVue